Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127413041 | 12741304 | 1 | I | 2016 | 20160908 | 20160914 | 20160914 | EXP | US-AMGEN-USASP2016121857 | AMGEN | 53.00 | YR | A | M | Y | 0.00000 | 20160914 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127413041 | 12741304 | 1 | PS | NEULASTA | PEGFILGRASTIM | 1 | Unknown | UNK, AFTER CHEMO | U | 125031 | UNKNOWN FORMULATION | ||||||||
| 127413041 | 12741304 | 2 | C | CARBOPLATIN. | CARBOPLATIN | 1 | UNK | 0 | |||||||||||
| 127413041 | 12741304 | 3 | C | ETOPOSIDE. | ETOPOSIDE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127413041 | 12741304 | 1 | Product used for unknown indication |
| 127413041 | 12741304 | 2 | Colorectal cancer |
| 127413041 | 12741304 | 3 | Colorectal cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127413041 | 12741304 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127413041 | 12741304 | Pyrexia | |
| 127413041 | 12741304 | Tachycardia | |
| 127413041 | 12741304 | White blood cell count increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |